When executed with precision and transparency, ECAs can enhance trial efficiency, expand access and support evidence—while ...

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the ...

Shares of Sun Pharma Advanced Research Company Ltd (SPARC) plunged nearly 20% on Wednesday on the NSE, after the company ...

The final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...

IVMED-85 is a preservative-free, non-atropine daily drop that slows myopia progression by strengthening scleral and corneal ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results ...

Three BriaCell posters and one publish-only abstract highlight robust clinical data from Bria-IMT™ and Bria-OTS™ studies in ...

The trial is evaluating EB103, which is a CD19-redirected ARTEMIS® T-cell therapy, in adult patients (aged 18 and older) with ...

| When clinical trial steps are managed separately, the study suffers from compounded delays. Discover proven solutions from ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

The analysts are supporting the company’s potential in the broader mental health sector, demonstrating the transformative ...